Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain management after immediate dental implant placement
ISRCTN90549666Phase 4Completed
- Sponsor
- Changshu Yuhui Dental Hospital
- Start
- Sep 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of liposomal bupivacaine and articaine in postoperative pain (2 arms), sponsored by Changshu Yuhui Dental Hospital. Primary endpoint: Postoperative pain severity at 24 hours. Started Sep 2025; status: completed.
02
Drugs
liposomal bupivacainearticaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ISRCTN90549666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN90549666.